4 Healthcare Stock Stories for Thursday Wellness

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Johnson & Johnson (NYSE:JNJ): Current price $74.08

The European Commission has sent antitrust objections to Novartis (NYSE:NVS) and Johnson & Johnson in regards to a pay-for-delay arrangement that might have deterred sales of generic versions of pain killer fentanyl in the Netherlands. The Commission charged that the Dutch divisions of both firms made a so-called co-promotion agreement in July 2005 to avert competing against each other, which results deprived Dutch fentanyl customers access to a less expensive pain killer for 17 months.

jnj

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business